Novartis aims to resubmit Galvus in U.S. n 2009

(Reuters) - Novartis expects to start a new study in the fourth-quarter this year.



"It will likely take until at least the end of 2008 to complete," Novartis pharma development head James Shannon said on a conference call. "And then we would propose to resubmit the dossier to the FDA sometime in mid-2009."


Read more at Reuters.com Government Filings News

Choking risk for babies prompts Gerber recall

(Reuters) - The packages were distributed in the United States, Puerto
Rico and the Caribbean, the company said on its Web site.




Novartis said the recall was minor and that it would have no
financial impact on the group, nor would the group make
provisions to cover any losses from the recall.


Read more at Reuters.com Mergers News